ArticleFrontiers in immunology2026

DNER drives glycolytic reprogramming in renal cell carcinoma by activating the JAK2/STAT3 signaling pathway.

Anrui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.